RFS
TECH icon

Rockefeller Financial Services’s Bio-Techne TECH Stock Holding History

Rockefeller Financial Services’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-196
Closed -$5K – 576
2016
Q1 		$5K Buy
+196
New +$4.32K ﹤0.01% 569

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Rockefeller Financial Services's TECH Position: Q2 2016 in Review

Rockefeller Financial Services sold out of Bio-Techne (TECH) in Q2 2016, closing a stake of 196 shares — an estimated $5K sold.

Rockefeller Financial Services first reported a position in TECH in Q1 2016 and held it in 1 quarter. The position peaked at $5K in Q1 2016. 288 funds tracked by Wall St. Rank hold TECH as of Q2 2016.

  • Rockefeller Financial Services reported no remaining Bio-Techne position as of Q2 2016 after selling out during the quarter.
  • Rockefeller Financial Services sold 196 Bio-Techne shares in Q2 2016, an estimated $5K.
  • Rockefeller Financial Services first reported a position in Bio-Techne in Q1 2016 and held it in 1 quarter.
  • Rockefeller Financial Services's Bio-Techne position peaked at $5K in Q1 2016.
  • 288 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2016.

Based on Rockefeller Financial Services's 13F filing for Q2 2016, filed 20 Jul 2016.